Free Trial

Enavate Sciences Gp, LLC Top Holdings and 13F Report (2026)

About Enavate Sciences Gp, LLC

Investment Activity

  • Enavate Sciences Gp, LLC has $351.51 million in total holdings as of March 31, 2026.
  • Enavate Sciences Gp, LLC owns shares of 7 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
  • About 8.24% of the portfolio was sold this quarter.
  • This quarter, Enavate Sciences Gp, LLC has purchased 7 new stocks and bought additional shares in 0 stocks.
  • Enavate Sciences Gp, LLC sold shares of 2 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

SIONNA THERAPEUTICS INC
$99,344,223
Immunome
$79,033,784
ZENAS BIOPHARMA INC
$76,619,558
BRIDGEBIO ONCOLOGY THERAPEUT
$23,511,167

Largest Sales this Quarter

Immunome
1,154,784 shares (about $25.26M)
CAMP4 THERAPEUTICS CORP
844,905 shares (about $3.73M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofEnavate Sciences Gp, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
SIONNA THERAPEUTICS INC
$99,344,2230.0%2,478,03028.3%COM
Immunome, Inc. stock logo
IMNM
Immunome
$79,033,784$25,255,126 â–¼-24.2%3,613,79922.5%Medical
ZENAS BIOPHARMA INC
$76,619,5580.0%3,919,15921.8%COM
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$41,199,3140.0%7,788,15011.7%Medical
BRIDGEBIO ONCOLOGY THERAPEUT
$23,511,1670.0%2,626,9466.7%COM NEW
UPSTREAM BIO INC
$22,137,3270.0%2,459,7036.3%COM
CAMP4 THERAPEUTICS CORP
$9,661,957$3,726,031 â–¼-27.8%2,190,9202.7%COM

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data